Casson Mann has been appointed to design a permanent exhibition that highlights antimicrobial resistance for a bold new public space at the Fleming Centre, due to open in 2028 at St Mary’s Hospital in Paddington, London.

GSK will become the first partner of the new Imperial-led Fleming Initiative, which aims to tackle antimicrobial resistance globally.